Hepatobiliary Cancer

  • Chien Peter Chen
  • Kim Huang
  • Mack RoachIII


∼22,000 cases and 17,000 deaths per year in the U.S. Frequency: hepatocellular carcinoma (most common) > gallbladder cancer > extrahepatic cholangiocarcinoma > intrahepatic cholangiocarcinoma (least common).


Gallbladder Cancer Intrahepatic Cholangiocarcinoma Stage Group Microscopic Residual Disease Extrahepatic Cholangiocarcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Abou-Alfa GK, Schwartz L, Ricci S, et al. Phase II Study of Sorafenib in Patients with Advanced Hepatocellular Carcinoma. J Clin Oncol 2006;24: 4293-4300.PubMedCrossRefGoogle Scholar
  2. Alden ME, Mohiuddin M. The Impact of Radiation Dose in Combined External Beam and Intraluminal Ir-192 Brachytherapy for Bile Duct Cancer. Int J Radiat Oncol Biol Phys 1994;28:945-951.PubMedCrossRefGoogle Scholar
  3. Borgelt BB, Gelber R, Brady LW, et al. The Palliation of Hepatic Metastases: Results of the Radiation Therapy Oncology Group Pilot Study. Int J Radiat Oncol Biol Phys 1981;7:587-591.PubMedCrossRefGoogle Scholar
  4. Borghero Y, Crane CH, Szklaruk J, et al. Extrahepatic Bile Duct Adenocarcinoma: Patients at High-Risk for Local Recurrence Treated with Surgery and Adjuvant Chemoradiation Have an Equivalent Overall Survival to Patients with Standard-Risk Treated with Surgery Alone. Ann Surg Oncol 2008;15: 3147-3156.PubMedCrossRefGoogle Scholar
  5. Crane CH, MacDonald KO, Vauthey JN, et al. Limitations of Conventional Doses of Chemoradiaion for Unresectable Biliary Cancer. Int J Radiat Oncol Biol Phys 2002;53:969-974.PubMedCrossRefGoogle Scholar
  6. Cubertafond P, Mathonnet M, Gainant A, et al. Radical Surgery For Gallbladder Cancer. Results of the French Surgical Association Survey. Hepatogastroenerology 1999;46:1567-1571.Google Scholar
  7. Czito BG, Hurwitz HI, Clough RW, et al. Adjuvant External-Beam Radiotherapy with Concurrent Chemotherapy After Resection of Primary Gallbladder Carcinoma: A 23-Year Experience. Int J Radiat Oncol Biol Phys 2005;62: 1030-1034.PubMedCrossRefGoogle Scholar
  8. Dawson LA, McGinn CJ, Normolle D, et al. Escalated Focal Liver Radiation and Concurrent Hepatic Artery Flourodeoxyuridine for Unresectable Intrahepatic Malignancies. J Clin Oncol 2000;18:2210-2218.PubMedGoogle Scholar
  9. Dawson LA, Normolle D, Balter JM, et al. Analysis of Radiation-Induced Liver Disease Using the Lyman NTCP Model. Int J Radiat Oncol Biol Phys 2002;53:810-821.PubMedCrossRefGoogle Scholar
  10. Duffy A, Capanu M, Abou-Alfa GK, et al. Gallbladder Cancer (GBC): 10-Year Experience at Memorial Sloan Kettering Cancer Centre (MSKCC). J Surg Oncol 2008; 98:485-489.PubMedCrossRefGoogle Scholar
  11. Lau WY, Lai EC, Leung TW, et al. Adjuvant Intra-arterial Iodine-131 Labeled Lipiodol for Resectable Hepatocellular Carcinoma: A Prospective Randomized Trial – Update on 5-Year and 10-Year Survival. Ann Surg 2008;247:43-48.PubMedCrossRefGoogle Scholar
  12. Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in Advanced Hepatocellular Carcinoma. N Engl J Med 2008;359:378-390.PubMedCrossRefGoogle Scholar
  13. Mojica P, Smith D, and Ellenhorn J. Adjuvant Radiation Therapy is Associated with Improved Survival for Gallbladder Carcinoma with Regional Metastatic Disease. J Surg Oncol 2007;96:8-13.PubMedCrossRefGoogle Scholar
  14. Mornex F, Girarda N, Beziat C, et al. Feasibility and efficacy of high-dose three-dimensional radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies – mature results of the French phase II RTF-1 trial. Int J Radiat Oncol Biol Phys 2006;66:1152-8.PubMedCrossRefGoogle Scholar
  15. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Hepatobiliary Cancers. Available at: Accessed on May 11, 2009.
  16. Nelson JW, Ghafoori AP, Willett CG, et al. Concurrent Chemoradiotherapy in Resected Extrahepatic Cholangiocarcinoma. Int J Radiat Oncol Biol Phys 2009;73:148-153.PubMedCrossRefGoogle Scholar
  17. North JH, Pack MS, Hong C, et al. Prognostic Factors for Adenocarcinoma of the Gallbladder: An analysis of 162 Cases. Am Surg 1998;64:437-440.PubMedGoogle Scholar
  18. Russell AH, Clyde C, Wasserman TH, et al. Accelerated Hyperfractionated Hepatic Irradiation in the Management of Patients with Liver Metastases: Results of the RTOG Dose Escalating Protocol. Int J Radiat Oncol Biol Phys 1993;27:117-123.PubMedCrossRefGoogle Scholar
  19. Seong J, Shim SJ, Lee IJ, et al. Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy. Int J Radiat Oncol Biol Phys 2007;67:1037-1042.PubMedCrossRefGoogle Scholar
  20. Schoenthaler R, Phillips TL, Efrid JT, et al. Carcinoma of the Extrahepatic Bile Ducts, the University of California at San Francisco Experience. Annals of Surgery 1994;219:267-274.PubMedCrossRefGoogle Scholar
  21. Tse RV, Kim JJ, Hawkins M, et al. Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangenic Sarcoma. J Clin Oncol 2008;Epub Jan 2.Google Scholar
  22. Todoroki T, Ohara K, Kawamoto T, et al. Benefits of Adjuvant Radiotherapy After Radical Resection of Locally Advanced Main Hepatic Duct Carcinoma. Int J Radiat Oncol Biol Phys 2000;46:581-587.PubMedCrossRefGoogle Scholar
  23. Wang SJ, Fuller CD, Kim JS, et al. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. J Clin Oncol 2008; 26: 2116-2117.Google Scholar
  24. Zeng ZC, Tang ZY, Fan J, et al. A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma. Cancer J 2004;10:307-316.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York 2010

Authors and Affiliations

  • Chien Peter Chen
    • 1
  • Kim Huang
    • 1
  • Mack RoachIII
    • 2
  1. 1.Radiation OncologyUniversity of California San FranciscoSan FranciscoUSA
  2. 2.Department of Radiation OncologyUniversity of California San FranciscoSan FranciscoUSA

Personalised recommendations